TAXONOMY PATHWAYS

taXonomy Pathways combines closed claims with labs, EHR, including clinician notes, to deliver a comprehensive view of the dementia journey. Our Alzheimer’s cohort demonstrates the depth of our data:

• 
  Closed claims: 1.4 M patients (2016–2024)
• 
  Pharmacy claims: 1.2 M patients (≈ 88 % of the closed‑claims cohort)
• 
  EHR data: 0.7 M patients (≈ 49 %)
• 
  Lab data: 0.9 M patients (≈ 65 %), including APOE, Aβ42/40 and tau measurements

Fill out the form to schedule a meeting and explore our Alzheimer’s dataset.